Read Time: 13 minutes
The Division Bench of Chief Justice Mohammad Rafiq & Justice Atul Sreedharan recently pulled up the State Govt for non availability of oxygen in the State.
“There is no reason why it cannot invest an amount of Rs.50 Crore so as to set up one PSA Oxygen Plants in each of them. There is no liquid oxygen manufacturing plant in the entire State. Since there is a possibility of third wave of Covid-19 in the coming months, it is the duty of the State to take steps to ensure that such plants are set up in the State.”, the Court observed.
The Court while taking note of installation of 5 out of 8 PSA Oxygen Plants approved by the Central Govt under PM CARES (Prime Minister's Citizen Assistance and Relief in Emergency Situations Fund) Fund remarked that the portrayal regarding availability of oxygen in the action plan submitted by the State before this Court is far from reality.
The Court further added that, “People are dying in many hospitals only because of non-availability of oxygen.” & thereby observed that all private hospitals should be mandated to set up their own Air Separation Units. The Court also focused on regular & punctual procurement of oxygen to ensure that all Private & Govt hospitals continue to have the quantity of oxygen necessary to maintain the required pressure of oxygen supply to all the patients under their treatment so that no patients succumb to CoVID due to shortage of non supply of oxygen.
The Bench in the present matter made these observations while hearing a suo motu petition registered as Public Interest Litigation for benefit of residents of the State suffering from Coronavirus, aggrieved by inaction on the part of the various State Authorities in not providing them timely and proper treatment.
During the hearing, the Court also took note of the state of affairs existing for CoVID management:
On the aspect of administration of Remdesivir injection, the Bench directed the state to ensure availability of injections at the earliest & further noted that the decision for administration should be left to the discretion of the treating doctor.
“We see no justification on the insistence of providing Remdesivir to only such patients who are on oxygen support, particularly when oxygen, as a commodity, itself has become so scarce. There appears to be no logic behind this policy.”, the Bench remarked.
Thereafter, the Court issued the following directions:
The matter will now be heard on May 6, 2021.
Case Title: In Reference (Suo Motu) vs. Union of India and others| W.P. No.8914/2020
Please Login or Register